MedPath

Use of Ultrasonic Bone Scalpel in Adolescent Idiopathic Scoliosis

Not Applicable
Completed
Conditions
Adolescent Idiopathic Scoliosis
Posterior Spinal Fusion
Interventions
Procedure: Posterior Spinal Fusion
Device: Ultrasonic Bone Scalpel
Registration Number
NCT02781324
Lead Sponsor
University of Colorado, Denver
Brief Summary

The primary purpose of this randomized trial is to compare the efficacy of an ultrasonic bone scalpel (or osteotome device) with standard of care surgical instruments during posterior spine fusion with instrumentation.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
66
Inclusion Criteria
  1. 10-18 years of age
  2. Diagnosis of Adolescent Idiopathic Scoliosis (AIS)
  3. Scheduled for a posterior spinal fusion (without Schwab Grade II or higher osteotomy)
Exclusion Criteria
  1. Plan for a posterior column osteotomy of Schwab Grade II or higher
  2. Prior spinal surgery
  3. Magnetic Resonance Imaging (MRI) abnormalities (such as syrinx and/or chiari malformations)
  4. Subjects with medical comorbidities (e.g. heart, lung, kidney disease)
  5. Subjects with bleeding diatheses
  6. Non-idiopathic etiology for scoliosis

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Ultrasonic Bone Scalpel GroupUltrasonic Bone ScalpelSurgeons will use the ultrasonic bone scalpel, to their discretion, along with standard of care manual devices when performing the posterior spinal fusion.
Ultrasonic Bone Scalpel GroupPosterior Spinal FusionSurgeons will use the ultrasonic bone scalpel, to their discretion, along with standard of care manual devices when performing the posterior spinal fusion.
Standard of Care GroupPosterior Spinal FusionSurgeons will use, to their discretion, only standard of care manual devices when performing the posterior spinal fusion.
Primary Outcome Measures
NameTimeMethod
Estimated Blood Loss/LevelIntraoperative

Estimated blood loss is being obtained from the report generated by the cell saver.

Secondary Outcome Measures
NameTimeMethod
Procedure Time (Minutes)Intraoperative (for duration of the procedure)
Number of Patients With Intraoperative and Postoperative Blood Transfusions in the Ultrasonic Bone Scalpel Group and Standard of Care GroupIntraoperative, Short Term Postoperative (end of procedure until hospital discharge, up to 7 days after surgery)

This outcome measure measures the number of patients with intraoperative and postoperative blood transfusions placed in the Ultrasonic Bone Scalpel Group and the Standard of Care Group.

Trial Locations

Locations (1)

Children's Hospital Colorado

🇺🇸

Aurora, Colorado, United States

© Copyright 2025. All Rights Reserved by MedPath